US OptionsDetailed Quotes
CSL250516C320000
- 38.60
- 0.000.00%
15min DelayTrading Apr 11 15:56 ET
0.00High0.00Low
0.00Open38.60Pre Close0 Volume7 Open Interest320.00Strike Price0.00Turnover55.56%IV-7.04%PremiumMay 16, 2025Expiry Date65.76Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9851Delta0.0011Gamma5.86Leverage Ratio-0.0985Theta0.0795Rho5.77Eff Leverage0.0232Vega
Carlisle Companies Stock Discussion
Sign in to post a comment
In this video i deep dive into GOOG, META, FIX, and CSL earnings reports! I also own all these stocks and i show you my entire stock portfolio! 🫡
$Meta Platforms (META.US)$ $Alphabet-C (GOOG.US)$ $Comfort Systems USA (FIX.US)$ $Carlisle Companies (CSL.US)$ $Alphabet-A (GOOGL.US)$
$Meta Platforms (META.US)$ $Alphabet-C (GOOG.US)$ $Comfort Systems USA (FIX.US)$ $Carlisle Companies (CSL.US)$ $Alphabet-A (GOOGL.US)$
From YouTube
1
1
The bull market seems intact, seeing global stocks mostly march up overnight. And move further above their immediate term trend lines. But. Speed bumps are on the horizon.
Bets are on for an almost 1% swing, in either direction for the S&P500 $S&P 500 Index (.SPX.US)$, after the US jobs report is released Friday. It’s a big deal for the direction of markets in the short...
Bets are on for an almost 1% swing, in either direction for the S&P500 $S&P 500 Index (.SPX.US)$, after the US jobs report is released Friday. It’s a big deal for the direction of markets in the short...
From YouTube
7
1
1
The share price has tracked EPS growth, suggesting market sentiment towards the shares remains steady. The stock's recent performance has improved, with a better one-year total shareholder return than the five-year return. Dividends have enhanced the total shareholder return.
CSL anticipates robust annualized double-digit earnings growth over the medium term, driven by strong patient demand for its immunoglobulins franchise. The company has bounced back from the pandemic's impact on its blood plasma collections.
The positive trends in Carlisle Companies' ROCE and its ability to consistently reinvest in itself make it an attractive investment. Investors are expecting more growth in the future. However, it's important to check if these trends will continue.
The stock is seen as overpriced by valuation models, making it less attractive for purchase. With the company's low likelihood of significant earnings growth, its investment appeal is diminished. Profits could be made if share prices meet realistic values.
Carlisle Companies' growth is praised, but future performance remains key. Dividends have boosted total shareholder return, despite short-term performance being below market. Effective business strategy is expected to continue but investors should note identified risks.
1
Despite no insider trades recently at Carlisle Companies, management's considerable stock ownership aligns their interests with shareholders'. Yet, no insider buying in the last year is concerning.
This downgrade hints at a downturn in business conditions for Carlisle Companies, suggesting worse than industry performance and potential market caution. The downgrade may increase the company's debt pressure, hinting at possible fiscal tightening.
No comment yet
Bobi2206 : great but stock price cui